Science · 1995 · 505 citations · 38 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyOncogenesCyclin-dependent KinasesMalignant NeoplasmsOncogene ActivationOncogenic ProliferationProto-oncogene ActivationRas Family OncogenesAgarCdc25 Phosphatase SignalingCdc25 PhosphatasesMultigene FamiliesOncogenic Cell Cycle SignalingPhosphatasesSoft Agar Colony Formation AssaysThreonine Phosphorylation
Cyclin-dependent kinases (CDKs) are activated by CDC25 phosphatases, which remove inhibitory phosphate from tyrosine and threonine residues. In human cells, CDC25 proteins are encoded by a multigene family, consisting of CDC25A, CDC25B, and CDC25C. In rodent cells, human CDC25A or CDC25B but not CDC25C phosphatases cooperate with either Ha-RASG12V or loss of RB1 in oncogenic focus formation. Such transformants were highly aneuploid, grew in soft agar, and formed high-grade tumors in nude mice. Overexpression of CDC25B was detected in 32 percent of human primary breast cancers tested. The CDC25 phosphatases may contribute to the development of human cancer.
38
WAF1, a potential mediator of p53 tumor suppression
Wafik S. El‐Deiry, Takashi Tokino, Victor E. Velculescu et al. · Cell · 1993 · 8.4K citations
p21 is a universal inhibitor of cyclin kinases
Yue Xiong, Gregory J. Hannon, Hui Zhang et al. · Nature · 1993 · 3.4K citations